PMG
TEVA icon

ProVise Management Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

ProVise Management Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,272
Closed -$224K – 320
2014
Q2 		$224K Hold
4,272
– – 0.05% 282
2014
Q1 		$226K Buy
+4,272
New +$197K 0.05% 272

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

ProVise Management Group's TEVA Position: Q3 2014 in Review

ProVise Management Group sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2014, closing a stake of 4,272 shares — an estimated $224K sold.

ProVise Management Group first reported a position in TEVA in Q1 2014 and held it in 2 quarters. The position peaked at $226K in Q1 2014. 773 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

  • ProVise Management Group reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2014 after selling out during the quarter.
  • ProVise Management Group sold 4,272 Teva Pharmaceutical Industries Limited shares in Q3 2014, an estimated $224K.
  • ProVise Management Group first reported a position in Teva Pharmaceutical Industries Limited in Q1 2014 and held it in 2 quarters.
  • ProVise Management Group's Teva Pharmaceutical Industries Limited position peaked at $226K in Q1 2014.
  • 773 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2014.

Based on ProVise Management Group's 13F filing for Q3 2014, filed 10 Nov 2014.